International Medicine: Currently not involved in the research, production, and sale of brain-machine interface products.

Announcement of abnormal fluctuations in the international medical stock market trading. The company's fundamentals have not undergone any significant changes. The company's main business is in the field of big health medical services and the application of modern medical technology transformation. The company's subsidiary medical institutions mainly provide high-level comprehensive medical services to patients. Currently, the company is not involved in the research, production, and sales of brain-computer interface products. The application of brain-computer interfaces in the medical field is currently in a key transition phase from the laboratory to clinical applications. The revenue from the rehabilitation training systems and surgeries related to brain-computer interfaces used in the company's medical institutions accounts for a very small proportion of the company's operating income, and has basically no impact on the company's performance. Please pay attention to the risks of trading company stocks in the secondary market, make rational decisions, and invest prudently.